JNK inhibitors (BioFocus)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJNK inhibitors (BioFocus)
Drug Alias NameBF-67193BF-67192
ClassificationSmall molecules
Mechanisms of Actionc-Jun N-terminal kinase 1 inhibitorsc-Jun N-terminal kinase 3 inhibitorsAnticancer protein kinase inhibitors +[4] 
Targetsc-Jun N-terminal kinase 1c-Jun N-terminal kinase 2c-Jun N-terminal kinase 3
Therapy Area/IndicationsInflammationDiabetes MellitusNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioFocus DPI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioFocus DPI
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A